The News
  • Latest news
  • Archives
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • 2000
    • 1999

The News

Portfolio Companies in the News

» 10/01/12
Omthera Pharmaceuticals announces Positive Long Term Bioavailability data comparing Epanova™ to Lovaza®

Click here for the site of Sofinnova Ventures, our sister firm in San Francisco http://www.sofinnova.com

  • Home
  • About us
  • The news
  • The team
  • Investments
  • Entrepreneur section
  • Contact
  • Terms & policies

Copyright 2000 - 2007 Sofinnova Partners - All rights reserved


Sofinnova

  • HOME
  • ABOUT US
    • Our investment strategy
    • Our Funds
    • Our Philosophy
    • Our history
    • FAQ
  • THE NEWS
    • Latest news
    • Archives
  • THE TEAM
    • Presentation
    • Life Sciences
      • Denis Lucquin
      • Antoine Papiernik
      • Graziano Seghezzi
      • Rafaèle Tordjman
      • Rob Woodman
      • Mano Iyer
      • Katie Ellias
      • Ram Aiyar
    • Technology
      • Olivier Sichel
      • Alessio Beverina
      • Nicolas Autret
    • Corporate Team
      • Monique Saulnier
    • Venture Partners
      • Gérard Hascoët
      • Jean-Claude Martinez
      • Alain Tingaud
    • Support Team
      • Stéphanie Huiban
      • Sarah Lafaye
      • Nathalie Loreaux
      • Stéphane Marrache
      • Annie Tréhard
      • Emma Duheille
      • Lamia Idrissi
      • Sandrine Le Penru
      • Elodie Perez
      • Dominique Verdier
  • INVESTMENTS
    • Presentation
    • Technology
      • Disruptive technologies & Cleantech
      • Consumer electronics
      • Internet & e-business
      • Telecom & Software
      • Wireless
    • Life Sciences
      • Drug Delivery
      • Medical Device
      • Platform discovery
      • Drug Development
    • Awards
    • Success stories
  • ENTREPRENEUR SECTION
    • Seeking financing
    • Join a start-up
  • CONTACT
    • Press Kit
Site Sofinnova en français
Sitemap
  • Home
  • Archives